Cellectar Biosciences, Inc. (CLRB)
CIK 1279704 · all EDGAR filings →
Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.
Shares outstanding over time
Latest: 9.5M shares as of Aug 11, 2026 (10-Q). Share count fell from 57.4M to 2.9M between May 13, 2014 and Aug 1, 2014, a pattern consistent with a reverse split (roughly 1-for-20); simultaneous issuance can skew the raw ratio, so confirm in the filings. The red bar marks the cliff.
Cash runway
Going-concern warning
auditor flagged substantial doubt
The company itself flagged going-concern doubt in a filing.
Full breakdown: cash runway tool · source filing →
Warrants
| Tranche | Warrants | Exercise price | Term | Notes |
|---|---|---|---|---|
| Tranche Warrants | 13.2M | not tagged | — | — |
| Two Thousand Twenty Six May Tranche C Common Warrants | 13.2M | $2.65 | — | — |
| Two Thousand Twenty Six May Tranche Common Warrants | 13.2M | $2.65 | — | — |
| Two Thousand Twenty Six May Tranche B Common Warrants | 13.2M | $2.65 | — | — |
| Two Thousand Twenty Six May Pre Funded Warrants | 9.2M | $0.00001 | — | — |
| Two Thousand Twenty Five October Series One Common Warrants | 1.0M | $6 | — | — |
| Two Thousand Twenty Five October Series Two Common Warrants | 1.0M | $6 | — | — |
| Two Thousand Twenty Six May Placement Agent Warrants | 792,362 | $4.1075 | — | — |
| Two Thousand Twenty Five July Common Warrants | 436,000 | $5.25 | — | — |
| Two Thousand Twenty Four Tranche B Warrants | 139,877 | $120 | — | — |
| Two Thousand Twenty Four Tranchea Warrants | 114,773 | $75.6 | — | — |
| Two Thousand Twenty Five Representative Warrants | 82,800 | $7.75 | 5y | — |
Tranches exactly as the company dimensioned them in its 10-Q filed Aug 13, 2026 →. Groupings can overlap (a “Series E and F” row is not additive with a “Series E” row), so do not sum this column. A tranche the filer did not tag is absent here, not absent from the cap table. DOWN-ROUND = the filer tagged price-protection accounting scoped to that tranche.
Warrants outstanding: 550,000 underlying shares, as reported Dec 31, 2014 (10-K).
Reported exercise price: $5.25 (aggregate figure as tagged; individual tranches vary).
Rough fully diluted estimate: 10.0M = 9.5M O/S + 550,000 warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.
Convertible notes
No convertible-note facts tagged in the 10-Q filed Aug 13, 2026. If convertible notes exist, their terms live in exhibit prose for this filer and are not parsed; absence of a tag is not proof of absence. The exhibits are the ground truth.
Fully diluted build-up
Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.
| Shares outstanding | 9.5M | Aug 11, 2026 |
| + Tranche Warrants (if exercised) | 13.2M | May 5, 2026 |
| + Two Thousand Twenty Six May Tranche C Common Warrants (if exercised) | 13.2M | Jun 30, 2026 |
| + Two Thousand Twenty Six May Tranche Common Warrants (if exercised) | 13.2M | Jun 30, 2026 |
| + Two Thousand Twenty Six May Tranche B Common Warrants (if exercised) | 13.2M | Jun 30, 2026 |
| + Two Thousand Twenty Six May Pre Funded Warrants (if exercised) | 9.2M | Jun 30, 2026 |
| + Two Thousand Twenty Five October Series One Common Warrants (if exercised) | 1.0M | Jun 30, 2026 |
| + Two Thousand Twenty Five October Series Two Common Warrants (if exercised) | 1.0M | Jun 30, 2026 |
| + Two Thousand Twenty Six May Placement Agent Warrants (if exercised) | 792,362 | Jun 30, 2026 |
| + Two Thousand Twenty Five July Common Warrants (if exercised) | 436,000 | Jun 30, 2026 |
| + Two Thousand Twenty Four Tranche B Warrants (if exercised) | 139,877 | Jun 30, 2026 |
| + Two Thousand Twenty Four Tranchea Warrants (if exercised) | 114,773 | Jun 30, 2026 |
| + Two Thousand Twenty Five Representative Warrants (if exercised) | 82,800 | Jun 30, 2026 |
| Fully diluted estimate | 75.1M | +695.1% vs O/S |
Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.
Registrations and offerings
Registered offering capacity on live registrations: $160.7Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted
Last 12 months: 3 executed · 3 registered.
Full history and shelf status: offering checker · S-3 shelf checker
Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.
Keep going: float checker · offering calendar · short-squeeze screener · full CLRB workspace